Trish Wozniak

Seasoned PA-C with over 10 years of experience and a robust background in telemedicine, notably at Headlands ATS. Licensed in over ten states. Excelled in delivering mental health and substance abuse care, leveraging clinical expertise and acute care management skills. Proven track record in improving patient outcomes through innovative treatment plans and diagnostic excellence. Demonstrates exceptional autonomy and a patient-first approach.

Vast experience with workers' compensation care, family practice, pain management, weight loss, and HRT.

• Sub Principal Investigator, Biolclinica- Myovant MVT-601-3102 SPIRIT 2, An International Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate Relugolix Administered with and without Low-Dose Estradiol and Norethindrone Acetate in Women with Endometriosis-Associated Pain
• Sub Principal Investigator, Bioclinica- Myovant-601-3003 Liberty 1, An International Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate Relugolix CoAdministered with and without Low-Dose Estradiol and Norethindrone Acetate in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids
• Sub Principal Investigator, Garfield Registry - Thrombosis Research Institute, 01/2015, 10/2020

• National Institute of Health GCP Certificate, 03/2018
• IATA 1.5 Certification, 09/2019, 09/2021
• ASCLS P.A.C.E 'Transferring of Dangerous Goods' Certification, 06/2019, 06/2021
• National Institute of Health N.O.E.R 'Protecting Human Research Participants', 03/2018
• DOT/CDL Medical examiner, 10/2027
• CAOCH certified
• NIOSH certified

• Indiana
• California
• Florida
• New York
• Illinois
• Michigan
• New Jersey
• Massachusetts
• North Dakota
• Pennsylvania
• Texas
• Washington
• Wisconsin

• NCCPA Certification
• AAPA
• Certified in Medical Cannabis